Our results here, demonstrating a significant role of PXR in HNSCC pathogenesis, highlight the importance of further studying this nuclear receptor as a factor contributing to HNSCC molecular heterogeneity and variable therapeutic response. This evidence concerns the gene NR1I2 and head and neck squamous cell carcinoma.